The genetic markers of Parkinson’s disease BCL2, TBP,and TAF1 exert greater regulatory influence on acylcarnitinemetabolism enzymes, while PARP1 equally affects enzymesinvolved in both amino acid and acylcarnitine metabolism(Fig. 1). This evidence concerns the gene TAF1 and Parkinson disease.